Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News on Diabetes

Novo Nordisk, maker of obesity drug Wegovy, to cut 9,000 jobs to sharpen focus, meet competition

Danish pharmaceutical company Novo Nordisk, maker of weight-loss drug Wegovy, said Wednesday it would cut 9,000 jobs, 5,000 of them in Denmark, in order to strengthen the company’s focus on growth opportunities in obesity and diabetes medications

The Independent UK

Junk food leads to more children being obese than underweight for first time

Cheap ultra-processed food behind rise in overweight children, with one in 10 now obese globally, says Unicef

The Guardian - UK

Almost half of those with diabetes don’t know they have it. Are you one of them?

Diabetes affects 38.4 million Americans, according to the Centers for Disease Control and Prevention

The Independent UK

From analysis to the latest developments in health,
read the most diverse news in one place.

UK ‘falling behind’ when it comes to diabetes diagnosis, study says

Among western European countries, only Switzerland and France had lower diagnosis rates than the UK

The Independent UK

Weight-loss jabs are not enough to tackle the obesity crisis, experts warn

THE UK’S OBESITY CHALLENGE : Weight-loss drug Mounjaro will be rolled out to a quarter of a million NHS patients. But leading experts tell Rebecca Thomas and Alicja Hagopian that weight-loss jabs alone will not be enough to solve the obesity crisis

The Independent UK

WHO has added GLP-1 drugs to the essential medicines list. Here’s what that means

GLP-1 drugs were initially developed for diabetes, but have become wildly popular weight-loss drugs too

The Independent UK

WHO Backs Weight-loss Drugs, Urges Cheap Generics

The World Health Organization recommended a range of blockbuster weight-loss drugs to treat diabetes and obesity globally for the first time on Friday, calling for cheap generic versions to be made available for people in developing countries.

International Business Times

Read news from The Economist, FT, and more,
with one subscription

Error means 55,000 patients require diabetes retests after potential misdiagnoses

More than 55,000 patients may require new blood tests to receive an accurate blood glucose reading

The Independent UK

Softies take a hit as nation sours on sweetened drinks

Health organisations say data revealing fewer Aussies are drinking sweetened drinks is encouraging, but more work is needed to incentivise healthy choices.

AAP

New technology for diabetic pregnant women will reduce risk of miscarriage and stillbirth

The new technology, known as a hybrid closed loop system, will help reduce the risk of stillbirth and miscarriage

The Independent UK

Mapped: NHS patients facing postcode lottery for weight-loss jab Mounjaro

It’s estimated that 3.4 million people in the UK could benefit from taking a weight-loss jab like Mounjaro

The Independent UK

Scientists say there is no link between ‘microdosing’ weight-loss drugs and living longer

It is ‘too early’ to know whether small doses of weight-loss drugs can help you live longer, experts say

The Independent UK

Weight-loss jabs: Wes Streeting pledges to do more to stop people being ‘priced out’

The Health Secretary said he was really concerned about the rising costs of the jabs.

Evening Standard

Energy drinks crackdown sees Prime and Monster banned for under-16s

Around 100,000 children are thought to consume at least one high-caffeine energy drink every day

The Independent UK

Get all your
news in one place.

100’s of premium titles.
One news app.

The Guardian - UK

‘No place in children’s hands’: under-16s in England to be banned from buying energy drinks

Government to ban sale of energy drinks with more than 150mg of caffeine, citing concerns over obesity and lack of concentration

Woman & Home

How do weight loss jabs work? Dr Amir Khan reveals all you need to know

Whether you know Mounjaro from Wegovy or it's all Ozempic to you, you'd have to be living (blissfully) under a rock to miss the chatter about weight loss jabs

International Business Times UK

Man Gets Worms in His Brain After Eating Breakfast Staple Wrong for Years – Could You Be at Risk?

A 52-year-old American developed 'brain worms' after years of eating 'soft' bacon; here's what actually causes neurocysticercosis, what the case report says, and how to cook pork safely to cut risk.

Evening Standard

Weight loss drugs could slash hospital risk for heart failure patients

Heart failure happens when the heart is unable to pump blood around the body properly.

Get all your
news in one place.

100’s of premium titles.
One news app.

International Business Times UK

Is RFK Jr.'s 'Brain Worm' Behind His Claims—Like Diagnosing a Child Without a Medical Degree? Here's What Doctors Say

HHS Sec. RFK Jr. claims he spots child illnesses visually—no degree needed. Ties to 2010 parasite? CDC stats debunk claims.

International Business Times

From Diagnosis to Advocacy: How Dr. Keith Hersey is Guiding Patients Through Diabetes and GLP-1 Therapy

Hersey is slated to speak at an international conference in Orlando and will address a local diabetes support group in Raleigh on October 1.

Benzinga

UK Patients Scramble For Mounjaro As Eli Lilly's 170% Price Hike Plan Sparks Shortages, Health Fears

Patients across the United Kingdom are struggling to obtain the weight-loss and diabetes drug Mounjaro as demand surges ahead of a sharp price increase set for September.

The Independent UK

‘I lost more than 2 stone on Mounjaro - but my hair started to fall out’

Rhiannon Anne Griffiths-Bowen says the weight-loss benefits of taking Mounjaro outweighed the issue of hair loss

The Independent UK

Daily weight loss pill achieves main goal in late-stage trial

Data from an earlier study of the drug in patients without diabetes sent company shares tumbling

Benzinga

Eli Lilly's Obesity Pill Shows Big Wins In Weight, Blood Sugar And Heart Risk Factors

Eli Lilly and Co. (NYSE:LLY) on Tuesday released topline results from the Phase 3 ATTAIN-2 trial, evaluating oral orforglipron in adults with obesity or overweight and type 2 diabetes.

The Independent UK

True cost of the UK’s obesity crisis revealed – and how weight-loss jabs could be the answer

SPECIAL REPORT: The UK has an obesity epidemic, with levels having doubled since the 1990s. Could increasing the rollout of weight-loss drugs ease the burden on the overstretched NHS? Alicja Hagopian and Rebecca Thomas report

1 2 3 4 5

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

the World Health Organization

the Centers for Disease Control and Prevention

187 stories

BMJ

101 stories

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.